Beacon Gene Therapy Laru-zova Achieves Landmark Success in Pivotal XLRP Trial
In a significant advancement for ocular gene therapy and the treatment of rare inherited retinal...
Knowledge and News for the Global Fight Against Cancer.
In a significant advancement for ocular gene therapy and the treatment of rare inherited retinal...
London, UK – September 21, 2026 – In a pivotal "capital markets day" held in...
In a landmark transaction poised to redefine the competitive landscape of oncology, Australian biotechnology firm...
An emerging biotech firm, North Immunology, has successfully navigated a complex financial landscape to go...
Lisata Therapeutics has announced a definitive agreement to acquire Marea Therapeutics in a strategic stock-for-stock...
The biopharmaceutical landscape is currently experiencing a period of significant flux, marked by breakthrough gene...
The biopharmaceutical landscape is currently undergoing a dynamic transformation, characterized by shifting geopolitical alliances, a...
Xenon Pharmaceuticals, a biopharmaceutical company focused on developing therapies for neurological disorders, announced on September...
The biotechnology sector is experiencing a remarkable resurgence in 2026, with initial public offerings (IPOs)...
In a landmark strategic move set to reshape the landscape of cardiometabolic disease treatment, pharmaceutical...